| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine
|
Hoogendoorn, Martine
|
|
2019
|
22 |
3 |
p. 313-321
|
article
|
| 2 |
Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports
|
Snider, Julia Thornton
|
|
2019
|
22 |
3 |
p. 332-339
|
article
|
| 3 |
Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data
|
Fawsitt, Christopher G.
|
|
2019
|
22 |
3 |
p. 303-312
|
article
|
| 4 |
Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma
|
Huo, Jinhai
|
|
2019
|
22 |
3 |
p. 284-292
|
article
|
| 5 |
Copyright/Subscription
|
|
|
2019
|
22 |
3 |
p. A3
|
article
|
| 6 |
Correction
|
|
|
2019
|
22 |
3 |
p. 383
|
article
|
| 7 |
Correction
|
|
|
2019
|
22 |
3 |
p. 383
|
article
|
| 8 |
Correction
|
|
|
2019
|
22 |
3 |
p. 383
|
article
|
| 9 |
Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions
|
Parkinson, Bonny
|
|
2019
|
22 |
3 |
p. 293-302
|
article
|
| 10 |
Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data
|
Holleman, Marscha S.
|
|
2019
|
22 |
3 |
p. 322-331
|
article
|
| 11 |
Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups
|
Feng, Yan
|
|
2019
|
22 |
3 |
p. 355-361
|
article
|
| 12 |
Editorial Board
|
|
|
2019
|
22 |
3 |
p. A4
|
article
|
| 13 |
Evaluating Canadians’ Values for Drug Coverage Decision Making
|
Rizzardo, Shirin
|
|
2019
|
22 |
3 |
p. 362-369
|
article
|
| 14 |
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
|
Brazier, John
|
|
2019
|
22 |
3 |
p. 267-275
|
article
|
| 15 |
Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE
|
Oluboyede, Yemi
|
|
2019
|
22 |
3 |
p. 348-354
|
article
|
| 16 |
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
|
Bullement, Ash
|
|
2019
|
22 |
3 |
p. 276-283
|
article
|
| 17 |
Table of Contents
|
|
|
2019
|
22 |
3 |
p. A1-A2
|
article
|
| 18 |
Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials
|
Arbuckle, Rob
|
|
2019
|
22 |
3 |
p. 340-347
|
article
|
| 19 |
Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018
|
Watts, Rory D.
|
|
2019
|
22 |
3 |
p. 377-382
|
article
|
| 20 |
Valuation of Health States Considered to Be Worse Than Death—An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies
|
Gandhi, Mihir
|
|
2019
|
22 |
3 |
p. 370-376
|
article
|
Journal description